Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our opinions or reviews. Learn how we make money.

How to buy Baxter International stock | $79.09

Own Baxter International stock in just a few minutes.

Posted

Fact checked

Baxter International Inc is a medical instruments & supplies business based in the US. Baxter International shares (BAX) are listed on the NYSE and all prices are listed in US Dollars. Baxter International employs 50,000 staff and has a trailing 12-month revenue of around USD$11.4 billion.

How to buy shares in Baxter International

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Baxter International Find the stock by name or ticker symbol: BAX. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Baxter International reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$79.09, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Baxter International, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Baxter International. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Baxter International share price

Use our graph to track the performance of BAX stocks over time.

Baxter International shares at a glance

Information last updated 2020-09-25.
Latest market closeUSD$79.09
52-week rangeUSD$69.1 - USD$95.19
50-day moving average USD$82.9251
200-day moving average USD$84.87
Wall St. target priceUSD$96.25
PE ratio 43.7598
Dividend yield USD$0.98 (1.25%)
Earnings per share (TTM) USD$1.788

Compare trading platforms

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Available asset types Stock trade fee Option trade fee Annual fee
Vanguard
Stocks,Mutual funds,ETFs,Forex
$0
$1
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Robinhood
Stocks,Options,ETFs,Cryptocurrency
$0
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
TD Ameritrade
Stocks,Bonds,Options,Mutual funds,ETFs,Forex,Futures
$0
or $25 If it is broker-assisted
$0 + $0.65/contract,
or $25 Broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
Interactive Brokers
Stocks,Bonds,Options,Mutual funds,Index funds,ETFs,Forex,Futures,Cash
$0
$0 + $0.65/contract, $1 minimum
0%
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Tastyworks
Stocks,Options,ETFs,Futures
$0
Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg
Futures: $2.50/contract to open, $0 to close
0%
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Baxter International stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Baxter International price performance over time

Historical closes compared with the close of $79.09 from 2020-09-29

1 week (2020-09-23) 0.97%
1 month (2020-09-01) -7.55%
3 months (2020-07-01) -9.41%
6 months (2020-04-01) 0.55%
1 year (2019-09-30) -9.58%
2 years (2018-09-28) 2.59%
3 years (2017-09-29) 26.04%
5 years (2015-09-30) 140.76%

Is Baxter International under- or over-valued?

Valuing Baxter International stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Baxter International's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Baxter International's P/E ratio

Baxter International's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 44x. In other words, Baxter International shares trade at around 44x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Baxter International's PEG ratio

Baxter International's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.4297. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Baxter International's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Baxter International's EBITDA

Baxter International's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$2.8 billion.

The EBITDA is a measure of a Baxter International's overall financial performance and is widely used to measure a its profitability.

Baxter International financials

Revenue TTM USD$11.4 billion
Operating margin TTM 17.08%
Gross profit TTM USD$4.9 billion
Return on assets TTM 6.58%
Return on equity TTM 11.7%
Profit margin 8.1%
Book value $15.932
Market capitalisation USD$39.8 billion

TTM: trailing 12 months

Shorting Baxter International shares

There are currently 3.8 million Baxter International shares held short by investors – that's known as Baxter International's "short interest". This figure is 11.6% down from 4.4 million last month.

There are a few different ways that this level of interest in shorting Baxter International shares can be evaluated.

Baxter International's "short interest ratio" (SIR)

Baxter International's "short interest ratio" (SIR) is the quantity of Baxter International shares currently shorted divided by the average quantity of Baxter International shares traded daily (recently around 3.5 million). Baxter International's SIR currently stands at 1.11. In other words for every 100,000 Baxter International shares traded daily on the market, roughly 1110 shares are currently held short.

However Baxter International's short interest can also be evaluated against the total number of Baxter International shares, or, against the total number of tradable Baxter International shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Baxter International's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Baxter International shares in existence, roughly 10 shares are currently held short) or 0.0076% of the tradable shares (for every 100,000 tradable Baxter International shares, roughly 8 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Baxter International.

Find out more about how you can short Baxter International stock.

Baxter International's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Baxter International.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Baxter International's total ESG risk score

Total ESG risk: 25.47

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Baxter International's overall score of 25.47 (as at 08/01/2020) is nothing to write home about – landing it in it in the 48th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Baxter International is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Baxter International's environmental score

Environmental score: 1.01/100

Baxter International's environmental score of 1.01 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Baxter International is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Baxter International's social score

Social score: 16.22/100

Baxter International's social score of 16.22 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Baxter International is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Baxter International's governance score

Governance score: 7.26/100

Baxter International's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that Baxter International is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Baxter International's controversy score

Controversy score: 3/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Baxter International scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Baxter International hasn't always managed to keep its nose clean.

Environmental, social, and governance (ESG) summary

Baxter International Inc was last rated for ESG on: 2020-08-01.

Total ESG score 25.47
Total ESG percentile 48.36
Environmental score 1.01
Environmental score percentile 1
Social score 16.22
Social score percentile 1
Governance score 7.26
Governance score percentile 1
Level of controversy 3

Baxter International share dividends

51%

Dividend payout ratio: 50.56% of net profits

Recently Baxter International has paid out, on average, around 50.56% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.25% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Baxter International shareholders could enjoy a 1.25% return on their shares, in the form of dividend payments. In Baxter International's case, that would currently equate to about $0.98 per share.

Baxter International's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.

Baxter International's most recent dividend payout was on 1 October 2020. The latest dividend was paid out to all shareholders who bought their shares by 28 August 2020 (the "ex-dividend date").

Have Baxter International's shares ever split?

Baxter International's shares were split on a 1841:1000 basis on 1 July 2015. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1841 shares. This wouldn't directly have changed the overall worth of your Baxter International shares – just the quantity. However, indirectly, the new 45.7% lower share price could have impacted the market appetite for Baxter International shares which in turn could have impacted Baxter International's share price.

Baxter International share price volatility

Over the last 12 months, Baxter International's shares have ranged in value from as little as $69.1 up to $95.19. A popular way to gauge a stock's volatility is its "beta".

BAX.US volatility(beta: 0.79)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Baxter International's is 0.7854. This would suggest that Baxter International's shares are less volatile than average (for this exchange).

Baxter International overview

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. It also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.

Frequently asked questions

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site